Heinz Koelbl led the peer-review process as the Associate Editor responsible for the paper.
Original Clinical Article
Safety and one year outcomes following vaginally assisted laparoscopic uterine sacropexy (VALUES) for advanced uterine prolapse
Article first published online: 31 MAY 2013
Copyright © 2013 Wiley Periodicals, Inc.
Neurourology and Urodynamics
How to Cite
Fayyad, A. M. and Siozos, C. S. (2013), Safety and one year outcomes following vaginally assisted laparoscopic uterine sacropexy (VALUES) for advanced uterine prolapse. Neurourol. Urodyn.. doi: 10.1002/nau.22433
Conflict of interest: None.
Contribution to authorship—A. Fayyad: Designed the study, analyzed the data, written the manuscript. C. Siozos: Analyzed the data, written the manuscript.
Details of ethical approval: Interventional Procedures Governance Committee of the Luton and Dunstable University Hospital approved the procedure as a modification of established technique (sacrohysteropexy), with regular audit of outcomes.
Presentation information: 38th Annual Society of Gynecologic Surgeons (SGS) Scientific Meeting, Baltimore, MD, April 13–15, 2012.
- Article first published online: 31 MAY 2013
- Manuscript Accepted: 16 APR 2013
- Manuscript Received: 24 FEB 2013
- uterine prolapse;
To assess the safety and outcomes of vaginally assisted laparoscopic uterine sacropexy (VALUES) as a surgical treatment for stage 3 and 4 uterine prolapse.
Seventy consecutive women with stage 3 and 4 uterine prolapse who underwent VALUES over 2-year period were prospectively evaluated. Women filled the Prolapse Quality of Life Questionnaire (P-QOL), and underwent examination using pelvic organ prolapse quantification system (POP-Q) pre- and post-operatively. In addition, patients filled the patient global impression of improvement questionnaire post-operatively. Mesh related complications were evaluated post-operatively. Patients were followed up at 3 and 12 months following surgery. This study reports the 12 months outcomes.
Sixty-four women (91.4%) reported cure of their prolapse symptoms. On examination, 67 women (95.7%) had POP-Q stage 0 or 1 uterine support at 12 months. Six women needed further surgical intervention for prolapse (8.5%); three women developed recurrent uterine prolapse and three other women developed symptomatic recurrent anterior vaginal wall prolapse. The total vaginal length was not different between the pre- and post-operative periods. Two patients developed mesh related complications. Significant improvement was noted in prolapse symptoms and quality of life.
VALUES is a safe and effective treatment for women with stage 3 and 4 uterine prolapse up to 12 months without the risk of vaginal shortening. Long-term results are needed to fully establish the value of this technique. Neurourol. Urodynam. © 2013 Wiley Periodicals, Inc.